Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL7408683 | 0.91 | BCL2L1 (0.39) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL276894 | 0.84 | ALDH1A1 (0.40) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL31609391 | 0.74 | ALOX15 (0.43) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL5356722 | 0.70 | ALOX15 (0.40) | ALOX15KDM4ERAB9AALDH1A1HPGD | |
| SCHEMBL2005730 | 0.70 | ALOX15 (0.40) | ALOX15KDM4EALDH1A1HPGDGAA | |
| SCHEMBL28564397 | 0.70 | ALOX15 (0.40) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL16915952 | 0.70 | ALOX15 (0.40) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL2005732 | 0.70 | ALOX15 (0.40) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL4397520 | 0.70 | KDM4E (0.41) | ALOX15KDM4ERAB9AALDH1A1NPC1 | |
| SCHEMBL28372316 | 0.70 | ALOX15 (0.40) | ALOX15KDM4ERAB9AALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104144930-A | New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same | SERVIER LAB | 2014-11-12 | — | — | CN | claimed |
| CN-1105030-C | Thermal waterless lithographic printing plate | KODAK POLYCHROME GRAPHICS CO (US) | 2003-04-09 | — | — | CN | claimed |
| CN-1269752-A | Thermal waterless lithographic printing plate | KODAK POLYCHROME GRAPHICS CO (US) | 2000-10-11 | — | — | CN | claimed |
| US-12605449-B2 | Drug-clay mineral complex containing phospholipid and oral administration composition including same | KOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES (KR) | 2026-04-21 | — | — | US | disclosed |
| US-12458702-B2 | Conjugate for targeting therapy | NATIONAL TAIWAN UNIVERSITY (TW) | 2025-11-04 | — | — | US | disclosed |
| US-12419964-B2 | Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload | ELI LILLY AND COMPANY (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250127916-A1 | ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD | ELI LILLY AND COMPANY | 2025-04-24 | — | — | US | disclosed |
| US-20240158410-A1 | CAMPTOTHECIN COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2024-05-16 | — | — | US | disclosed |
| CN-117835980-A | Tetrahydropyrazolopyridine analog ligand of NLRX1 and application thereof | 朗多生物制药股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20230310618-A1 | CONJUGATE FOR TARGETING THERAPY | NATIONAL TAIWAN UNIVERSITY (TW) | 2023-10-05 | — | — | US | disclosed |
| EP-4214200-A1 | LANCL LIGANDS | Nimmune Biopharma, Inc. (US) | 2023-07-26 | — | — | EP | disclosed |
| CN-1452731-A | On-press development of heat sensitive lithographic plates | TENG GARY GANGHUI (US) | 2003-10-29 | — | — | CN | disclosed |
| CN-1425141-A | Laser-induced thermal transfer recording process | DU PONT (US) | 2003-06-18 | — | — | CN | disclosed |
| CN-1105030-C | Thermal waterless lithographic printing plate | KODAK POLYCHROME GRAPHICS CO (US) | 2003-04-09 | — | — | CN | disclosed |
| CN-1269752-A | Thermal waterless lithographic printing plate | KODAK POLYCHROME GRAPHICS CO (US) | 2000-10-11 | — | — | CN | disclosed |
| US-5674879-A | Compositions including and methods of using conformationally restricted angiotensin II antagonist | G.D. SEARLE & CO. (US) | 1997-10-07 | — | — | US | disclosed |
| EP-0483851-B1 | Pyrazolyl acrylic acid derivatives, intermediates thereto, and agricultural/horticultural fungicides containing said derivatives | MITSUBISHI CHEM CORP (JP) | 1996-03-13 | — | — | EP | disclosed |
| US-5426105-A | Cardiovascular disorders | G.D. SEARLE & CO. (US) | 1995-06-20 | — | — | US | disclosed |
| US-5128350-A | PYRAZOLYL ACRYLIC ACID DERIVATIVES AND AGRICULTURAL/HORTICULTURAL FUNGICIDES CONTAINING SAID DERIVATIVES | MITSUBISHI KASEI CORPORATION (JP) | 1992-07-07 | — | — | US | disclosed |
| EP-0483851-A1 | Pyrazolyl acrylic acid derivatives, intermediates thereto, and agricultural/horticultural fungicides containing said derivatives | Mitsubishi Chemical Corporation (JP) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240158410-A1 | CAMPTOTHECIN COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | WEE1, WEE2, PCLAF | ALOX15 468/4885KDM4E 4411/4885RAB9A 1971/4885 |
| US-12419964-B2 | Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload | NECTIN4, SDC4, EPCAM | ALOX15 4815/4885KDM4E 902/4885RAB9A 628/4885 |
| US-12605449-B2 | Drug-clay mineral complex containing phospholipid and oral administration composition including same | TOP1, ABCB11, PCTP | ALOX15 3102/4885KDM4E 749/4885RAB9A 1570/4885 |
| US-12458702-B2 | Conjugate for targeting therapy | FOLH1, CD44, SLC10A1 | ALOX15 3580/4885KDM4E 3131/4885RAB9A 425/4885 |
| US-20250127916-A1 | ANTIBODY DRUG CONJUGATE (ADC) TARGETING NECTIN 4 AND COMPRISING AN EXATECAN PAYLOAD | NECTIN4, SDC4, EPCAM | ALOX15 4815/4885KDM4E 902/4885RAB9A 628/4885 |
| US-20230310618-A1 | CONJUGATE FOR TARGETING THERAPY | FOLH1, CD44, SLC10A1 | ALOX15 3580/4885KDM4E 3131/4885RAB9A 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.